全文获取类型
收费全文 | 3577篇 |
免费 | 326篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 92篇 |
妇产科学 | 53篇 |
基础医学 | 591篇 |
口腔科学 | 60篇 |
临床医学 | 441篇 |
内科学 | 667篇 |
皮肤病学 | 70篇 |
神经病学 | 378篇 |
特种医学 | 206篇 |
外科学 | 460篇 |
综合类 | 69篇 |
一般理论 | 5篇 |
预防医学 | 393篇 |
眼科学 | 61篇 |
药学 | 211篇 |
中国医学 | 8篇 |
肿瘤学 | 125篇 |
出版年
2021年 | 49篇 |
2020年 | 31篇 |
2019年 | 51篇 |
2018年 | 58篇 |
2017年 | 49篇 |
2016年 | 62篇 |
2015年 | 42篇 |
2014年 | 70篇 |
2013年 | 124篇 |
2012年 | 149篇 |
2011年 | 174篇 |
2010年 | 107篇 |
2009年 | 106篇 |
2008年 | 124篇 |
2007年 | 138篇 |
2006年 | 134篇 |
2005年 | 151篇 |
2004年 | 128篇 |
2003年 | 142篇 |
2002年 | 132篇 |
2001年 | 108篇 |
2000年 | 109篇 |
1999年 | 91篇 |
1998年 | 58篇 |
1997年 | 58篇 |
1996年 | 37篇 |
1995年 | 40篇 |
1994年 | 40篇 |
1993年 | 33篇 |
1992年 | 62篇 |
1991年 | 65篇 |
1990年 | 58篇 |
1989年 | 70篇 |
1988年 | 67篇 |
1987年 | 78篇 |
1986年 | 58篇 |
1985年 | 57篇 |
1984年 | 57篇 |
1983年 | 47篇 |
1982年 | 38篇 |
1980年 | 39篇 |
1979年 | 43篇 |
1978年 | 51篇 |
1977年 | 30篇 |
1976年 | 36篇 |
1975年 | 38篇 |
1974年 | 34篇 |
1973年 | 33篇 |
1972年 | 43篇 |
1969年 | 28篇 |
排序方式: 共有3916条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
L D Nord R C Willis T S Breen T L Avery R A Finch Y S Sanghvi G R Revankar R K Robins 《Biochemical pharmacology》1989,38(20):3543-3549
The basis for the antitumor activities of the exocyclic amino nucleosides 4-amino-(ARPP) and 4-methoxy-8-(D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine (MRPP) was investigated. The primary target of these nucleosides appeared to be 5-phospho-alpha-D-ribofuranose-1-pyrophosphate (PRPP) synthetase. MRPP-5'-monophosphate was a competitive inhibitor (Ki = 40 microM) of the activation of this enzyme by the cofactor inorganic phosphate (K alpha = 2.2 mM). Consequently, ARPP and MRPP treatment of WI-L2 cultures rapidly inhibited both de novo pyrimidine and purine synthesis as well as the nucleotide salvage reactions dependent on PRPP, ARPP or MRPP treatment completely prevented [14C]bicarbonate incorporation into acid-soluble pyrimidine and purine nucleotides. The rate of salvage of [8-14C]hypoxanthine to form IMP was decreased by 85%. Treatment of cells with these agents caused a 50% reduction in the steady-state level of PRPP. When the capacity of the treated cells for sustained synthesis of PRPP was examined by adenine incorporation, the rate of adenine uptake was inhibited by greater than 50%. In vivo treatment of BDF1 mice with a single dose of ARPP (173 mg/kg) or MRPP (62 mg/kg) extended the mean life span of the mice, which had been inoculated intraperitoneally 1 day earlier with 1 x 10(6) L1210 murine leukemia cells, by 62 and 82% respectively. These studies indicate that MRPP and ARPP inhibit PRPP synthetase, and that PRPP synthetase may be a viable target in the development of certain antitumor agents. 相似文献
9.
10.
ALBERTO Q FARIAS LUCIANA L GONÇALVES EDUARDO LR CANÇADO ANTONIO C SEGURO SILVIA B CAMPOS CLARICE P ABRANTES-LEMOS FLAIR J CARRILHO 《Journal of gastroenterology and hepatology》2006,20(1):147-152
Background and Aims: Primary biliary cirrhosis (PBC) might be complicated by osteoporosis, whose etiology remains unknown but seems to be multifactorial. Prevalence rates of 30% to 60% for distal renal tubular acidosis (DRTA) have been reported in PBC patients, generally as incomplete DRTA. Although it is undisputed that a reduced bone mineral density (BMD) is the expected outcome among patients who have been suffering from longstanding chronic metabolic acidosis, it is unclear if incomplete DRTA is also associated with metabolic bone disease in PBC patients. The present study was undertaken to compare the BMD of PBC patients with and without DRTA.
Methods: The BMD of 23 PBC patients (11 with DRTA and 12 without), all with normal clearance of creatinine, was assessed by dual energy radiograph absorptiometry. The diagnosis of DRTA was made if the urine pH was above 5.4 in all samples after the oral acid overload, showing tubular inability to acidify urine in the presence of test-induced systemic metabolic acidosis.
Results: Densitometric signs of osteoporosis were found in 82% of DRTA cases and in 83% of patients without DRTA (difference not significant). There were no significant differences in BMD measurement, T and Z scores of patients with and without DRTA.
Conclusions: The present study could not support a correlation between the presence of DRTA and the bone loss observed in PBC patients. 相似文献
Methods: The BMD of 23 PBC patients (11 with DRTA and 12 without), all with normal clearance of creatinine, was assessed by dual energy radiograph absorptiometry. The diagnosis of DRTA was made if the urine pH was above 5.4 in all samples after the oral acid overload, showing tubular inability to acidify urine in the presence of test-induced systemic metabolic acidosis.
Results: Densitometric signs of osteoporosis were found in 82% of DRTA cases and in 83% of patients without DRTA (difference not significant). There were no significant differences in BMD measurement, T and Z scores of patients with and without DRTA.
Conclusions: The present study could not support a correlation between the presence of DRTA and the bone loss observed in PBC patients. 相似文献